India
oi-Deepika S
New Delhi, Apr 11: In a big relief amidst covid-19 vaccine shortage across the states, India likely to recieve Covid-19 vaccines from five additional manufacturers, ANI has reported, citing top government sources.
India is currently using Serum Institute’s Covishield and Bharat Biotech’s Covaxin for restricted emergency use.
“We can expect five more vaccines by Q3 2021. These vaccines are Sputnik V vaccine (in collaboration with Dr. Reddy’s), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila’s vaccine, and Bharat Biotech’s Intranasal Vaccine,” the sources told ANI.
“Sputnik is expected to be available latest by June, if all goes well Johnson and Johnson ( Bio E) will be available by August, Cadilla Zydus will also be available by August, Novavex (Serum) by September and Nasal…